INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | -22.6% | 7,381 | 0.0% | 0.01% | -13.3% |
| Q2 2023 | $301 | +2.4% | 7,381 | -6.3% | 0.02% | +15.4% |
| Q1 2023 | $294 | +7.3% | 7,881 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $274 | -99.9% | 7,859 | -0.2% | 0.01% | -38.1% |
| Q3 2022 | $441,000 | +8.1% | 7,872 | -0.3% | 0.02% | +16.7% |
| Q2 2022 | $408,000 | -28.9% | 7,894 | 0.0% | 0.02% | -21.7% |
| Q1 2022 | $574,000 | -38.5% | 7,894 | -0.1% | 0.02% | -20.7% |
| Q4 2021 | $933,000 | -17.4% | 7,898 | -6.1% | 0.03% | -19.4% |
| Q3 2021 | $1,129,000 | +88.8% | 8,412 | +127.7% | 0.04% | +80.0% |
| Q2 2021 | $598,000 | +564.4% | 3,694 | -42.4% | 0.02% | +900.0% |
| Q1 2017 | $90,000 | -24.4% | 6,412 | -29.4% | 0.00% | -33.3% |
| Q4 2016 | $119,000 | -25.2% | 9,077 | -2.9% | 0.00% | -40.0% |
| Q3 2016 | $159,000 | – | 9,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |